Eradication of Pseudomonas aeruginosa biofilm using quercetin-mediated copper oxide nanoparticles incorporated in the electrospun polycaprolactone nanofibrous scaffold

Microb Pathog. 2023 Dec:185:106453. doi: 10.1016/j.micpath.2023.106453. Epub 2023 Nov 15.

Abstract

Pseudomonas aeruginosa is an opportunistic bacterial pathogen that form biofilms in chronic wounds and is difficult to treat with standard treatment methods. In the present study, flavonoid quercetin-mediated CuONPs (Que-CuONPs) were successfully synthesized and incorporated in the electrospun polycaprolactone (Que-CuONPs-PCL) nanofibrous membrane to eradicate the burn wound infection causing P. aeruginosa biofilm. The fabricated scaffold Que-CuONPs-PCL was characterized using HR-SEM, EDX, XRD, and FTIR. The synthesized Que-CuONPs appeared as spherical in shape with the average size of 36 nm. The crystallite size of the synthesized CuONPs was calculated as 23 nm. Antibacterial activity results shows that the ZOI and MIC of Que-CuONPs against P. aeruginosa was found to be 20 mm and 5 μg/mL, respectively. Antibiofilm assay results indicate the pre-formed P. aeruginosa biofilm was completely eradicated by Que-CuONPs at 8-MIC. The Que-CuONPs-PCL nanofibrous scaffolds exhibits less cytotoxic effects on mouse fibroblast (L929) cells. Finally, this study highlights the fabricated Que-CuONPs-PCL nanofibrous scaffolds exhibits an excellent antibiofilm effect against P. aeruginosa biofilm with a great biocompatibility.

Keywords: Biocompatible drug; Copper oxide nanoparticles; Polycaprolactone nanofibrous scaffold; Pseudomonas aeruginosa biofilm; Quercetin; Wound infection.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Biofilms
  • Copper / pharmacology
  • Metal Nanoparticles*
  • Mice
  • Nanofibers*
  • Oxides
  • Pseudomonas aeruginosa
  • Quercetin / pharmacology

Substances

  • Quercetin
  • polycaprolactone
  • cuprous oxide
  • Copper
  • Anti-Bacterial Agents
  • Oxides